Seeking Growth Pref. Equity for Integrative & Functional Medicine Practice

Timoneer is an operationally focused Independent Sponsor seeking $3.25M in convertible preferred equity. The investment will be split between liquidity to existing shareholders ($1.5M), growth capital ($1.5M) to the balance sheet to fund de-novo expansion, plus fees and expenses ($250k). Structure provides meaningful downside protection via a 3x liquidation preference, while preserving the ability to convert into common equity (45% pro-forma) and capture a pro-rata share of the upside above the liquidation preference. Teaser below.